CaMKII oxidative activation and the pathogenesis of cardiac disease

Journal of Molecular and Cellular Cardiology

Volumn 73, Issue , 2014, Pages 112-116

  Luczak, Elizabeth D ^a   Anderson, Mark E ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Arrhythmia; Calcium; Heart failure; Mitochondria; Reactive oxygen species

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II INHIBITOR; CALCIUM ION; HOLOENZYME; METHIONINE; METHIONINE SULFOXIDE REDUCTASE A; MITO TEMPO; MITOCHONDRIA TARGETED ANTIOXIDANT; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RYANODINE RECEPTOR 2; UNCLASSIFIED DRUG;

ADRENERGIC STIMULATION; ANTIOXIDANT ACTIVITY; ARRHYTHMOGENESIS; AUTOPHOSPHORYLATION; AUTOREGULATION; CALCIUM SIGNALING; CELL DEATH; CELL FUNCTION; CELLULAR DISTRIBUTION; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME REGULATION; ENZYME STRUCTURE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART DEPOLARIZATION; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART MUSCLE INJURY; HEART RUPTURE; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMORAL IMMUNITY; HYPERGLYCEMIA; MITOCHONDRION; MORTALITY; MYOCARDITIS; NITROSYLATION; NONHUMAN; OLIGOMERIZATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REDUCTION; REVIEW; RISK FACTOR; SINUS NODE DISEASE; SUDDEN CARDIAC DEATH; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; ARRHYTHMIAS, CARDIAC; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; HEART DISEASES; HEART FAILURE; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 84901847600     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.02.004     Document Type: Review

References (58)

1. Tomaselli G.F., Barth A.S. Sudden cardio arrest: oxidative stress irritates the heart. Nat Med 2010, 16:648-649.
2. Swaminathan P.D., Purohit A., Hund T.J., Anderson M.E. Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ Res 2012, 110:1661-1677.
3. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
4. 2+/calmodulin-dependent protein kinase II. Biochem J 2002, 364:593-611.
5. Rosenberg O.S., Deindl S., Sung R.J., Nairn A.C., Kuriyan J. Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme. Cell 2005, 123:849-860.
6. Yang E., Schulman H. Structural examination of autoregulation of multifunctional calcium/calmodulin-dependent protein kinase II. J Biol Chem 1999, 274:26199-26208.
7. 2+/calmodulin-independence. Proc Natl Acad Sci U S A 1987, 84:5710-5714.
8. Meyer T., Hanson P.I., Stryer L., Schulman H. Calmodulin trapping by calcium-calmodulin-dependent protein kinase. Science 1992, 256:1199-1202.
9. Stratton M., Lee I.H., Bhattacharyya M., Christensen S.M., Chao L.H., Schulman H., et al. Activation-triggered subunit exchange between CaMKII holoenzymes facilitates the spread of kinase activity. Elife 2013, 3:e01610.
10. He B.J., Joiner M.L., Singh M.V., Luczak E.D., Swaminathan P.D., Koval O.M., et al. Oxidation of CaMKII determines the cardiotoxic effects of aldosterone. Nat Med 2011, 17:1610-1618.
11. Singh M.V., Swaminathan P.D., Luczak E.D., Kutschke W., Weiss R.M., Anderson M.E. MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction. J Mol Cell Cardiol 2012, 52:1135-1144.
12. Swaminathan P.D., Purohit A., Soni S., Voigt N., Singh M.V., Glukhov A.V., et al. Oxidized CaMKII causes cardiac sinus node dysfunction in mice. J Clin Invest 2011, 121:3277-3288.
13. Luo M., Guan X., Luczak E.D., Lang D., Kutschke W., Gao Z., et al. Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. J Clin Invest 2013, 123:1262-1274.
14. Purohit A., Rokita A.G., Guan X., Chen B., Koval O.M., Voigt N., et al. Oxidized CaMKII triggers atrial fibrillation. Circulation 2013, 128(16):1748-1757.
15. 2+ release. Circ Res 2003, 92:904-911.
16. Zhang T., Maier L.S., Dalton N.D., Miyamoto S., Ross J., Bers D.M., et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res 2003, 92:912-919.
17. Wu Y., Temple J., Zhang R., Dzhura I., Zhang W., Trimble R., et al. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation 2002, 106:1288-1293.
18. 2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart. J Clin Invest 2009, 119:986-996.
19. Zhang R., Khoo M.S., Wu Y., Yang Y., Grueter C.E., Ni G., et al. Calmodulin kinase II inhibition protects against structural heart disease. Nat Med 2005, 11:409-417.
20. Vila-Petroff M., Salas M.A., Said M., Valverde C.A., Sapia L., Portiansky E., et al. CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury. Cardiovasc Res 2007, 73:689-698.
21. Salas M.A., Valverde C.A., Sanchez G., Said M., Rodriguez J.S., Portiansky E.L., et al. The signalling pathway of CaMKII-mediated apoptosis and necrosis in the ischemia/reperfusion injury. J Mol Cell Cardiol 2010, 48:1298-1306.
22. Frantz S., Bauersachs J., Ertl G. Post-infarct remodelling: contribution of wound healing and inflammation. Cardiovasc Res 2009, 81:474-481.
23. Frangogiannis N.G., Smith C.W., Entman M.L. The inflammatory response in myocardial infarction. Cardiovasc Res 2002, 53:31-47.
24. Sanders P.N., Koval O.M., Jaffer O.A., Prasad A.M., Businga T.R., Scott J.A., et al. CaMKII is essential for the proasthmatic effects of oxidation. Sci Transl Med 2013, 5. [195ra97].
25. 2+/calmodulin-dependent protein kinase II delta mediates myocardial ischemia/reperfusion injury through nuclear factor-kappaB. Circ Res 2013, 112:935-944.
26. Zweier J.L., Talukder M.A. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006, 70:181-190.
27. Mudd J.O., Kass D.A. Tackling heart failure in the twenty-first century. Nature 2008, 451:919-928.
28. Swedberg K., Eneroth P., Kjekshus J., Wilhelmsen L. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation 1990, 82:1730-1736.
29. Gutierrez-Marcos F.M., Fernandez-Cruz A., Gutkowska J., Herrero C., Blesa A., Estrada V., et al. Atrial natriuretic peptide in patients with acute myocardial infarction without functional heart failure. Eur Heart J 1991, 12:503-507.
30. Beygui F., Collet J.P., Benoliel J.J., Vignolles N., Dumaine R., Barthelemy O., et al. High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction. Circulation 2006, 114:2604-2610.
31. 2+-calmodulin protein kinase II and promotes a death pathway conserved across different species. Circ Res 2009, 105:1204-1212.
32. Backs J., Song K., Bezprozvannaya S., Chang S., Olson E.N. CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J Clin Invest 2006, 116:1853-1864.
33. Bovo E., Lipsius S.L., Zima A.V. Reactive oxygen species contribute to the development of arrhythmogenic Ca(2)(+) waves during beta-adrenergic receptor stimulation in rabbit cardiomyocytes. J Physiol 2012, 590:3291-3304.
34. Gutierrez D.A., Fernandez-Tenorio M., Ogrodnik J., Niggli E. NO-dependent CaMKII activation during beta-adrenergic stimulation of cardiac muscle. Cardiovasc Res 2013, 100(3):392-401.
35. Wagner S., Rokita A.G., Anderson M.E., Maier L.S. Redox regulation of sodium and calcium handling. Antioxid Redox Signal 2013, 18:1063-1077.
36. Xie L.H., Chen F., Karagueuzian H.S., Weiss J.N. Oxidative-stress-induced afterdepolarizations and calmodulin kinase II signaling. Circ Res 2009, 104:79-86.
37. Song Y.H., Choi E., Park S.H., Lee S.H., Cho H., Ho W.K., et al. Sustained CaMKII activity mediates transient oxidative stress-induced long-term facilitation of L-type Ca(2+) current in cardiomyocytes. Free Radic Biol Med 2011, 51:1708-1716.
38. Wagner S., Ruff H.M., Weber S.L., Bellmann S., Sowa T., Schulte T., et al. Reactive oxygen species-activated Ca/calmodulin kinase IIdelta is required for late I(Na) augmentation leading to cellular Na and Ca overload. Circ Res 2011, 108:555-565.
39. 2+ sparks by mitochondria-derived reactive oxygen species in cardiac myocytes. Cardiovasc Res 2008, 77:432-441.
40. 2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res 2007, 73:631-640.
41. Eager K.R., Dulhunty A.F. Activation of the cardiac ryanodine receptor by sulfhydryl oxidation is modified by Mg2+ and ATP. J Membr Biol 1998, 163:9-18.
42. Eager K.R., Roden L.D., Dulhunty A.F. Actions of sulfhydryl reagents on single ryanodine receptor Ca(2+)-release channels from sheep myocardium. Am J Physiol 1997, 272:C1908-C1918.
43. Marengo J.J., Hidalgo C., Bull R. Sulfhydryl oxidation modifies the calcium dependence of ryanodine-sensitive calcium channels of excitable cells. Biophys J 1998, 74:1263-1277.
44. Wolf P.A., Abbott R.D., Kannel W.B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991, 22:983-988.
45. Shimano M., Shibata R., Inden Y., Yoshida N., Uchikawa T., Tsuji Y., et al. Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation. Heart Rhythm 2009, 6:935-940.
46. 2+ levels in right atrial myocardium of patients with atrial fibrillation. Circ Res 2010, 106:1134-1144.
47. 2+ leak promotes atrial fibrillation in mice. J Clin Invest 2009, 119:1940-1951.
48. Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005, 115:500-508.
49. Anilkumar N., Sirker A., Shah A.M. Redox sensitive signaling pathways in cardiac remodeling, hypertrophy and failure. Front Biosci (Landmark Ed) 2009, 14:3168-3187.
50. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010, 107:1058-1070.
51. Erickson J.R., Pereira L., Wang L., Han G., Ferguson A., Dao K., et al. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 2013, 502(7471):372-376.
52. Brookes P.S., Yoon Y., Robotham J.L., Anders M.W., Sheu S.S. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004, 287:C817-C833.
53. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat Med 2000, 6:513-519.
54. Clapham D.E. Calcium signaling. Cell 2007, 131:1047-1058.
55. Odagiri K., Katoh H., Kawashima H., Tanaka T., Ohtani H., Saotome M., et al. Local control of mitochondrial membrane potential, permeability transition pore and reactive oxygen species by calcium and calmodulin in rat ventricular myocytes. J Mol Cell Cardiol 2009, 46:989-997.
56. Joiner M.L., Koval O.M., Li J., He B.J., Allamargot C., Gao Z., et al. CaMKII determines mitochondrial stress responses in heart. Nature 2012, 491:269-273.
57. Yusuf S., Dagenais G., Pogue J., Bosch J., Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:154-160.
58. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002, 360:23-33.